Medtech M&A: medicinal remedy or legal quagmire

As part of our Tech M&A webinar series, we are hosting the second event in the series that will focus on navigating through the regulatory and technology complexities on top of the usual deal dynamics to successfully complete on a Medtech M&A transaction. 

Our expert panel will discuss, in particular, the specifics around data and cybersecurity, the regulatory landscape and the often complex IP issues as well as new legal questions arising from the use of new technologies.

Who should attend?

This webinar is relevant to CEOs, CTOs/CDOs, Chairpersons, FDs/CFOs, Non-Executive Directors, Shareholders and VC/PE investors in the Medtech, Digital Health and Technology sectors.